An interdisciplinary team of researchers has developed a smart patch designed to monitor a patient’s blood and release blood-thinning drugs as needed to prevent the occurrence of dangerous blood clots – a condition known as thrombosis.
In an animal model, the patch was shown to be more effective at preventing thrombosis than traditional methods of drug delivery. The work was done by researchers at North Carolina State University and the University of North Carolina at Chapel Hill.
Thrombosis occurs when blood clots disrupt the normal flow of blood in the body, which can cause severe health problems such as pulmonary embolism, heart attack or stroke. Current treatments often rely on the use of blood thinners, such as Heparin, which require patients to test their blood on a regular basis in order to ensure proper dosages. Too large a dose can cause problems such as spontaneous hemorrhaging, while doses that are too small may not be able to prevent a relapse of thrombosis.
“Our goal was to generate a patch that can monitor a patient’s blood and release additional drugs when necessary; effectively, a self-regulating system,” says Zhen Gu, co-corresponding author on a paper describing the work. Gu is an associate professor in the joint biomedical engineering program at NC State and UNC.
“Two years ago, I spoke with Zhen Gu about the significant clinical need for precise delivery of blood thinners,” says Caterina Gallippi, a co-corresponding author and associate professor in the joint biomedical engineering program. “We, together with Professor Yong Zhu in the mechanical engineering department at NC State, assembled a research team and invented this patch.”
The patch incorporates microneedles made of a polymer that consists of hyaluronic acid (HA) and the drug Heparin. The polymer has been modified to be responsive to thrombin, an enzyme that initiates clotting in the blood.
When elevated levels of thrombin enzymes in the bloodstream come into contact with the microneedle, the enzymes break the specific amino acid chains that bind the Heparin to the HA, releasing the Heparin into the blood stream.
“The more thrombin there is in the bloodstream, the more Heparin is needed to reduce clotting,” says Yuqi Zhang, a Ph.D. student in Gu’s lab and co-lead author of the paper. “So we created a disposable patch in which the more thrombin there is in the blood stream, the more Heparin is released.”
“We will further enhance the loading amount of drug in the patch. The amount of Heparin in a patch can be tailored to a patient’s specific needs and replaced daily, or less often, as needed,” says Jicheng Yu, a Ph.D. student in Gu’s lab and the other co-lead author of the paper. “But the amount of Heparin being released into the patient at any given moment will be determined by the thrombin levels in the patient’s blood.”
The research team tested the HA-Heparin smart patch in a mouse model. In the experiments, subjects were injected with large doses of thrombin, which would result in fatal blood clotting of the lungs if left untreated.
In the first experiment, mice were either left untreated, given a shot of Heparin, or given the HA-Heparin smart patch. The mice were injected with thrombin 10 minutes later. Fifteen minutes after the thrombin injection, only the mice who received no treatment died.
In the second experiment, the thrombin was injected six hours after treatment. Fifteen minutes after the thrombin injection, all of the mice with the HA-Heparin smart patch were fine, but around 80 percent of the mice that received the Heparin shot had died.
“We’re excited about the possibility of using a closed-loop, self-regulating smart patch to help treat a condition that affects thousands of people every year, while hopefully also driving down treatment costs,” Gu says. “This paper represents a good first step, and we’re now looking for funding to perform additional preclinical testing.”
The Latest on: Smart drug patch
via Google News
The Latest on: Smart drug patch
- American Express Plans Live Audio Webcast of the First Quarter 2020 Earnings Conference Callon March 23, 2020 at 8:21 am
plans to host a live audio webcast of its earnings conference call at 8:30 a.m. (ET) on Friday, April 24, 2020 to discuss first quarter 2020 financial results. The live audio webcast will be ...
- How wearables are transforming healthcareon March 23, 2020 at 4:22 am
C Smart patches capture hydration levels, core body temperature and heart rate among other ... Today, McKinsey and Company estimates that 20 percent of all healthcare costs result from lack of daily ...
- Coronavirus In CT: 11 Cases, Drive-Thru Testing Readyon March 13, 2020 at 3:11 pm
There are now 11 positive tests in Connecticut for the new coronavirus, according to the latest state data. CONNECTICUT — Coronavirus cases in Connecticut hit 11, including a Greenwich resident who ...
- Smart Pills Market Overall Study Market 2020-2027 | Proteus Digital Health, CapsoVision, Medtronic, Olympus Corporations, IntroMedicon March 13, 2020 at 12:11 pm
Stratagem Market Insights has announced the addition of the Smart Pills Market Report 2020 2027 Production Sales And Consumption Status And Prospects Professional Research The report classifies the ...
- 2020 NFL draft: Minnesota's Antoine Winfield Jr. (No. 61 prospect) making his own nameon March 13, 2020 at 6:33 am
Leading up to the 2020 NFL draft, which starts April 23, Yahoo Sports will count down our top 100 overall prospects. We’ll count them down in groups of five and 10 at a time, followed by in-depth ...
- Project aims to grow muscle tissue for wounded soldierson March 13, 2020 at 3:40 am
DARPA has awarded researchers $22m to develop ‘smart’ technology that combines artificial intelligence ... an acronym made from REgenerative electronic Patch through Advanced Intelligent Regulation.
- Smart Pills Market 2019 Analysis and Precise Outlook – CapsoVision, Medtronic, Olympus Corporationson March 12, 2020 at 9:18 am
Smart pills are capsule-sized ingestible medical devices consisting of elements such as sensors, cameras, patches, and trackers that help in better diagnostics, patient monitoring, as well as targeted ...
- COLUMN: It was just simple moldon March 6, 2020 at 8:00 pm
Well, when you pop the top on the old Tupperware, a bad smell immediately fills your nose and a bunch of green/black patches have spoiled ... or the smart phone or the combustion engine.
- Green Thoughts For Spring: Bronxville Mayoron March 4, 2020 at 6:47 am
Also cited were, "changing patterns of drug use including decriminalization of marijuana," and smart phones were named as a factor as they can be, "a significant source of both cognitive and ...
via Bing News